CD38 and acute myeloid leukemia: Several years ago, Keyhani and colleagues reported CD38 expression as a positive predictor of disease outcome in previously untreated adult AML and ALL, where CD38 levels correlate with prolonged complete remission and overall survival and represent and independent positive prognostic marker (85).